SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410939-22-000075
Filing Date
2022-05-18
Accepted
2022-05-18 16:24:52
Documents
12
Period of Report
2022-05-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K isee-20220512.htm   iXBRL 8-K 53988
  Complete submission text file 0001410939-22-000075.txt   190394

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20220512.xsd EX-101.SCH 1921
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20220512_lab.xml EX-101.LAB 24137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20220512_pre.xml EX-101.PRE 12525
6 EXTRACTED XBRL INSTANCE DOCUMENT isee-20220512_htm.xml XML 10555
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 22939424
SIC: 2834 Pharmaceutical Preparations